ARIAD PHARMACEUTICALS INC SEC Filings

Filed On	Filing
15 Oct 2021	Form 4: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other · Theseus Pharmaceuticals, Inc. Received 1,615,427 shares by conversion
15 Oct 2021	Form 3: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other · Theseus Pharmaceuticals, Inc.
07 Apr 2017	WESTFIELD CAPITAL MANAGEMENT COMPANY, L.P.
27 Feb 2017	CT ORDER
27 Feb 2017	15-12B
21 Feb 2017	AMENDMENT NO. 9
16 Feb 2017	S-8 POS
16 Feb 2017	S-8 POS
16 Feb 2017	S-8 POS
16 Feb 2017	S-8 POS
16 Feb 2017	S-8 POS
16 Feb 2017	S-8 POS
16 Feb 2017	S-8 POS
16 Feb 2017	S-8 POS
16 Feb 2017	S-8 POS
16 Feb 2017	Form 4: Schlesinger Sarah J., Director Gave 15,600 shares as a gift · Returned 55,508 shares to the issuer · Disposed of 140,000 Stock Option (Right to Buy) (Disposition to Issuer)
16 Feb 2017	Form 4: Clackson Timothy P, President, R&D, CSO Returned 220,444 shares to the issuer · Disposed of 234,125 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 87,530 Restricted Stock Units (Disposition to Issuer)
16 Feb 2017	Form 4: Haimovitz Jules, Director Returned 18,008 shares to the issuer · Disposed of 100,000 Stock Option (Right to Buy) (Disposition to Issuer)
16 Feb 2017	Form 4: Bickerstaff George, Director Returned 18,008 shares to the issuer · Disposed of 100,000 Stock Option (Right to Buy) (Disposition to Issuer)
16 Feb 2017	Form 4: Herron Jennifer Lyn, Exec V.P. Chief Comm'l Officer Returned 450 shares to the issuer · Disposed of 300,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 5,291 Restricted Stock Units (Disposition to Issuer)

Comments